The Alopecia Areata Patient Journey - Episode 10
Personalizing Treatment in Alopecia Areata
Published on:
A panelist discusses how determining whether a Janus kinase (JAK) inhibitor is the appropriate treatment for alopecia areata patients, which involves carefully evaluating disease severity, duration, and extent of hair loss, considering previous treatment failures, assessing patient comorbidities and risk factors, reviewing comprehensive laboratory results, discussing potential benefits vs risks of JAK therapy, and establishing realistic expectations about treatment timeline and potential adverse effects.
How do you decide whether a JAK inhibitor is an appropriate treatment option for a patient?
